London Loves Business, in its coverage of the study, reveals that since 2010, the pharmaceutical industry has been slapped with penalties amounting to $82.8 billion across more than 500 documented cases. These violations encompass issues such as disregarding drug and medical device safety standards, promoting medical products without proper authorization, breaching the False Claims Act, and a range of other transgressions.